For people with type 2 diabetes who are also taking insulin or sulfonylureas, the risk is substantially higher and requires active monitoring and likely dose reductions of the diabetes medications as weight and blood glucose improve
DPP-IV inhibitors, by virtue of their mechanism of action, increase the bioavailability of GLP-1 and GIP, leading to enhanced insulin secretion, improved glycemic control, and reduced insulin resistance in diabetes
& Cai, Y
Genetic predispositions in GLP-1 and related peptide pathwaysrevealed through testing like the Precision Peptide Genetic Test ($99 add-on with Medicaid or clinical assessment, $298 standalone)can support personalized conversations with your provider about expected side-effect tolerance, optimal dosing intervals, and long-term adherence
P2P review overturns denials about 35-45% of the time when the prescriber comes prepared with chart data and trial evidence
Features: 500mg L-Carnitine tartrate per capsule